nodes	percent_of_prediction	percent_of_DWPC	metapath
Ibandronate—FDPS—blood plasma—acquired immunodeficiency syndrome	0.0232	0.199	CbGeAlD
Ibandronate—FDPS—skin of body—acquired immunodeficiency syndrome	0.0112	0.0958	CbGeAlD
Ibandronate—FDPS—lymphoid tissue—acquired immunodeficiency syndrome	0.00904	0.0776	CbGeAlD
Ibandronate—FDPS—digestive system—acquired immunodeficiency syndrome	0.00893	0.0766	CbGeAlD
Ibandronate—FDPS—blood—acquired immunodeficiency syndrome	0.0085	0.073	CbGeAlD
Ibandronate—FDPS—bone marrow—acquired immunodeficiency syndrome	0.00823	0.0706	CbGeAlD
Ibandronate—FDPS—spinal cord—acquired immunodeficiency syndrome	0.00819	0.0703	CbGeAlD
Ibandronate—FDPS—vagina—acquired immunodeficiency syndrome	0.00788	0.0677	CbGeAlD
Ibandronate—FDPS—lung—acquired immunodeficiency syndrome	0.00746	0.064	CbGeAlD
Ibandronate—FDPS—nervous system—acquired immunodeficiency syndrome	0.0069	0.0592	CbGeAlD
Ibandronate—FDPS—central nervous system—acquired immunodeficiency syndrome	0.00665	0.057	CbGeAlD
Ibandronate—FDPS—brain—acquired immunodeficiency syndrome	0.00528	0.0453	CbGeAlD
Ibandronate—FDPS—lymph node—acquired immunodeficiency syndrome	0.0051	0.0438	CbGeAlD
Ibandronate—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.00055	0.000622	CcSEcCtD
Ibandronate—Back pain—Lamivudine—acquired immunodeficiency syndrome	0.000549	0.000621	CcSEcCtD
Ibandronate—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000547	0.000619	CcSEcCtD
Ibandronate—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000547	0.000619	CcSEcCtD
Ibandronate—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.000546	0.000618	CcSEcCtD
Ibandronate—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000546	0.000618	CcSEcCtD
Ibandronate—Muscle spasms—Lamivudine—acquired immunodeficiency syndrome	0.000546	0.000617	CcSEcCtD
Ibandronate—Rash—Didanosine—acquired immunodeficiency syndrome	0.000542	0.000614	CcSEcCtD
Ibandronate—Infection—Delavirdine—acquired immunodeficiency syndrome	0.000542	0.000613	CcSEcCtD
Ibandronate—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000542	0.000613	CcSEcCtD
Ibandronate—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000542	0.000613	CcSEcCtD
Ibandronate—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000542	0.000613	CcSEcCtD
Ibandronate—Headache—Didanosine—acquired immunodeficiency syndrome	0.000539	0.00061	CcSEcCtD
Ibandronate—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000537	0.000608	CcSEcCtD
Ibandronate—Shock—Delavirdine—acquired immunodeficiency syndrome	0.000537	0.000607	CcSEcCtD
Ibandronate—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.000536	0.000607	CcSEcCtD
Ibandronate—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000535	0.000606	CcSEcCtD
Ibandronate—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000535	0.000605	CcSEcCtD
Ibandronate—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.000534	0.000605	CcSEcCtD
Ibandronate—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000534	0.000604	CcSEcCtD
Ibandronate—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000531	0.000601	CcSEcCtD
Ibandronate—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.00053	0.0006	CcSEcCtD
Ibandronate—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.00053	0.0006	CcSEcCtD
Ibandronate—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.00053	0.0006	CcSEcCtD
Ibandronate—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000529	0.000599	CcSEcCtD
Ibandronate—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000528	0.000598	CcSEcCtD
Ibandronate—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000528	0.000597	CcSEcCtD
Ibandronate—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000527	0.000597	CcSEcCtD
Ibandronate—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000526	0.000596	CcSEcCtD
Ibandronate—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000526	0.000595	CcSEcCtD
Ibandronate—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000526	0.000595	CcSEcCtD
Ibandronate—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000526	0.000595	CcSEcCtD
Ibandronate—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000524	0.000594	CcSEcCtD
Ibandronate—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000524	0.000594	CcSEcCtD
Ibandronate—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000524	0.000593	CcSEcCtD
Ibandronate—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000522	0.000591	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000521	0.00059	CcSEcCtD
Ibandronate—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.00052	0.000589	CcSEcCtD
Ibandronate—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.00052	0.000589	CcSEcCtD
Ibandronate—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.00052	0.000588	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000519	0.000588	CcSEcCtD
Ibandronate—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000518	0.000587	CcSEcCtD
Ibandronate—Pain—Indinavir—acquired immunodeficiency syndrome	0.000516	0.000584	CcSEcCtD
Ibandronate—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000516	0.000584	CcSEcCtD
Ibandronate—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000516	0.000584	CcSEcCtD
Ibandronate—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000515	0.000583	CcSEcCtD
Ibandronate—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000515	0.000582	CcSEcCtD
Ibandronate—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000513	0.000581	CcSEcCtD
Ibandronate—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000513	0.00058	CcSEcCtD
Ibandronate—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000513	0.00058	CcSEcCtD
Ibandronate—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000512	0.00058	CcSEcCtD
Ibandronate—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000512	0.000579	CcSEcCtD
Ibandronate—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000512	0.000579	CcSEcCtD
Ibandronate—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000511	0.000578	CcSEcCtD
Ibandronate—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000511	0.000578	CcSEcCtD
Ibandronate—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.00051	0.000577	CcSEcCtD
Ibandronate—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000506	0.000573	CcSEcCtD
Ibandronate—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000506	0.000573	CcSEcCtD
Ibandronate—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000506	0.000573	CcSEcCtD
Ibandronate—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000505	0.000571	CcSEcCtD
Ibandronate—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000503	0.000569	CcSEcCtD
Ibandronate—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000503	0.000569	CcSEcCtD
Ibandronate—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000502	0.000568	CcSEcCtD
Ibandronate—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.0005	0.000566	CcSEcCtD
Ibandronate—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000497	0.000563	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000497	0.000562	CcSEcCtD
Ibandronate—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000496	0.000562	CcSEcCtD
Ibandronate—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000495	0.000561	CcSEcCtD
Ibandronate—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000495	0.000561	CcSEcCtD
Ibandronate—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000495	0.00056	CcSEcCtD
Ibandronate—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000495	0.00056	CcSEcCtD
Ibandronate—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000494	0.000559	CcSEcCtD
Ibandronate—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000493	0.000558	CcSEcCtD
Ibandronate—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000493	0.000558	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000492	0.000557	CcSEcCtD
Ibandronate—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000491	0.000556	CcSEcCtD
Ibandronate—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000491	0.000556	CcSEcCtD
Ibandronate—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.00049	0.000554	CcSEcCtD
Ibandronate—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.00049	0.000554	CcSEcCtD
Ibandronate—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000488	0.000552	CcSEcCtD
Ibandronate—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000487	0.000552	CcSEcCtD
Ibandronate—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000487	0.000552	CcSEcCtD
Ibandronate—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000487	0.000552	CcSEcCtD
Ibandronate—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000487	0.000551	CcSEcCtD
Ibandronate—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000486	0.00055	CcSEcCtD
Ibandronate—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000484	0.000548	CcSEcCtD
Ibandronate—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000483	0.000547	CcSEcCtD
Ibandronate—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000483	0.000547	CcSEcCtD
Ibandronate—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000483	0.000547	CcSEcCtD
Ibandronate—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000482	0.000546	CcSEcCtD
Ibandronate—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000481	0.000545	CcSEcCtD
Ibandronate—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.00048	0.000543	CcSEcCtD
Ibandronate—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.00048	0.000543	CcSEcCtD
Ibandronate—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000479	0.000542	CcSEcCtD
Ibandronate—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000478	0.000541	CcSEcCtD
Ibandronate—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000477	0.00054	CcSEcCtD
Ibandronate—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000477	0.00054	CcSEcCtD
Ibandronate—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000477	0.00054	CcSEcCtD
Ibandronate—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000476	0.000539	CcSEcCtD
Ibandronate—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000476	0.000539	CcSEcCtD
Ibandronate—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000475	0.000537	CcSEcCtD
Ibandronate—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000474	0.000537	CcSEcCtD
Ibandronate—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000472	0.000535	CcSEcCtD
Ibandronate—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000472	0.000534	CcSEcCtD
Ibandronate—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000472	0.000534	CcSEcCtD
Ibandronate—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000471	0.000534	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000471	0.000533	CcSEcCtD
Ibandronate—Rash—Stavudine—acquired immunodeficiency syndrome	0.000471	0.000533	CcSEcCtD
Ibandronate—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.00047	0.000532	CcSEcCtD
Ibandronate—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.00047	0.000532	CcSEcCtD
Ibandronate—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.00047	0.000532	CcSEcCtD
Ibandronate—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000469	0.000531	CcSEcCtD
Ibandronate—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000469	0.000531	CcSEcCtD
Ibandronate—Headache—Stavudine—acquired immunodeficiency syndrome	0.000468	0.000529	CcSEcCtD
Ibandronate—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000467	0.000529	CcSEcCtD
Ibandronate—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000466	0.000528	CcSEcCtD
Ibandronate—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000466	0.000528	CcSEcCtD
Ibandronate—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000466	0.000528	CcSEcCtD
Ibandronate—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000465	0.000527	CcSEcCtD
Ibandronate—Rash—Abacavir—acquired immunodeficiency syndrome	0.000464	0.000525	CcSEcCtD
Ibandronate—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000463	0.000524	CcSEcCtD
Ibandronate—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000463	0.000524	CcSEcCtD
Ibandronate—Headache—Abacavir—acquired immunodeficiency syndrome	0.000461	0.000521	CcSEcCtD
Ibandronate—Infection—Lamivudine—acquired immunodeficiency syndrome	0.00046	0.000521	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000459	0.00052	CcSEcCtD
Ibandronate—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000459	0.00052	CcSEcCtD
Ibandronate—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000459	0.000519	CcSEcCtD
Ibandronate—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000456	0.000516	CcSEcCtD
Ibandronate—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000456	0.000516	CcSEcCtD
Ibandronate—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000454	0.000514	CcSEcCtD
Ibandronate—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000453	0.000513	CcSEcCtD
Ibandronate—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000453	0.000513	CcSEcCtD
Ibandronate—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000451	0.00051	CcSEcCtD
Ibandronate—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000451	0.00051	CcSEcCtD
Ibandronate—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.00045	0.000509	CcSEcCtD
Ibandronate—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000449	0.000509	CcSEcCtD
Ibandronate—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000448	0.000507	CcSEcCtD
Ibandronate—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000446	0.000505	CcSEcCtD
Ibandronate—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000445	0.000503	CcSEcCtD
Ibandronate—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000444	0.000503	CcSEcCtD
Ibandronate—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000444	0.000502	CcSEcCtD
Ibandronate—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000444	0.000502	CcSEcCtD
Ibandronate—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000443	0.000502	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000442	0.000501	CcSEcCtD
Ibandronate—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000439	0.000497	CcSEcCtD
Ibandronate—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000438	0.000496	CcSEcCtD
Ibandronate—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000437	0.000494	CcSEcCtD
Ibandronate—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000436	0.000493	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000435	0.000493	CcSEcCtD
Ibandronate—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000435	0.000492	CcSEcCtD
Ibandronate—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000433	0.00049	CcSEcCtD
Ibandronate—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000433	0.00049	CcSEcCtD
Ibandronate—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000431	0.000488	CcSEcCtD
Ibandronate—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000431	0.000488	CcSEcCtD
Ibandronate—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000431	0.000488	CcSEcCtD
Ibandronate—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000431	0.000488	CcSEcCtD
Ibandronate—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000429	0.000486	CcSEcCtD
Ibandronate—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000427	0.000484	CcSEcCtD
Ibandronate—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000427	0.000483	CcSEcCtD
Ibandronate—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000422	0.000478	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000422	0.000478	CcSEcCtD
Ibandronate—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.00042	0.000475	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000419	0.000474	CcSEcCtD
Ibandronate—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000419	0.000474	CcSEcCtD
Ibandronate—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000418	0.000474	CcSEcCtD
Ibandronate—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000416	0.000471	CcSEcCtD
Ibandronate—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000416	0.00047	CcSEcCtD
Ibandronate—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000415	0.00047	CcSEcCtD
Ibandronate—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000415	0.00047	CcSEcCtD
Ibandronate—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000413	0.000467	CcSEcCtD
Ibandronate—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000412	0.000467	CcSEcCtD
Ibandronate—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000412	0.000467	CcSEcCtD
Ibandronate—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000409	0.000463	CcSEcCtD
Ibandronate—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000409	0.000463	CcSEcCtD
Ibandronate—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000409	0.000463	CcSEcCtD
Ibandronate—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000408	0.000461	CcSEcCtD
Ibandronate—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000406	0.00046	CcSEcCtD
Ibandronate—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000403	0.000456	CcSEcCtD
Ibandronate—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000403	0.000456	CcSEcCtD
Ibandronate—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000402	0.000455	CcSEcCtD
Ibandronate—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000401	0.000453	CcSEcCtD
Ibandronate—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.0004	0.000453	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.0004	0.000453	CcSEcCtD
Ibandronate—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000399	0.000452	CcSEcCtD
Ibandronate—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000399	0.000452	CcSEcCtD
Ibandronate—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000399	0.000451	CcSEcCtD
Ibandronate—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000399	0.000451	CcSEcCtD
Ibandronate—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000397	0.000449	CcSEcCtD
Ibandronate—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000396	0.000448	CcSEcCtD
Ibandronate—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000396	0.000448	CcSEcCtD
Ibandronate—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000391	0.000443	CcSEcCtD
Ibandronate—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.00039	0.000441	CcSEcCtD
Ibandronate—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000386	0.000437	CcSEcCtD
Ibandronate—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000386	0.000436	CcSEcCtD
Ibandronate—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000385	0.000436	CcSEcCtD
Ibandronate—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000384	0.000434	CcSEcCtD
Ibandronate—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000384	0.000434	CcSEcCtD
Ibandronate—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000384	0.000434	CcSEcCtD
Ibandronate—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000382	0.000432	CcSEcCtD
Ibandronate—Rash—Indinavir—acquired immunodeficiency syndrome	0.00038	0.000431	CcSEcCtD
Ibandronate—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.00038	0.00043	CcSEcCtD
Ibandronate—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000379	0.000429	CcSEcCtD
Ibandronate—Headache—Indinavir—acquired immunodeficiency syndrome	0.000378	0.000428	CcSEcCtD
Ibandronate—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000377	0.000427	CcSEcCtD
Ibandronate—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000373	0.000422	CcSEcCtD
Ibandronate—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000372	0.000421	CcSEcCtD
Ibandronate—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000368	0.000416	CcSEcCtD
Ibandronate—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000366	0.000414	CcSEcCtD
Ibandronate—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000366	0.000414	CcSEcCtD
Ibandronate—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000362	0.00041	CcSEcCtD
Ibandronate—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000362	0.00041	CcSEcCtD
Ibandronate—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000361	0.000408	CcSEcCtD
Ibandronate—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000359	0.000407	CcSEcCtD
Ibandronate—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000359	0.000406	CcSEcCtD
Ibandronate—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000358	0.000406	CcSEcCtD
Ibandronate—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000358	0.000405	CcSEcCtD
Ibandronate—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000357	0.000404	CcSEcCtD
Ibandronate—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000357	0.000404	CcSEcCtD
Ibandronate—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000348	0.000394	CcSEcCtD
Ibandronate—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000347	0.000392	CcSEcCtD
Ibandronate—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000345	0.000391	CcSEcCtD
Ibandronate—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000344	0.000389	CcSEcCtD
Ibandronate—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000344	0.000389	CcSEcCtD
Ibandronate—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000343	0.000389	CcSEcCtD
Ibandronate—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000342	0.000387	CcSEcCtD
Ibandronate—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000341	0.000386	CcSEcCtD
Ibandronate—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000339	0.000383	CcSEcCtD
Ibandronate—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000333	0.000377	CcSEcCtD
Ibandronate—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000332	0.000376	CcSEcCtD
Ibandronate—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000332	0.000376	CcSEcCtD
Ibandronate—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000328	0.000371	CcSEcCtD
Ibandronate—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000324	0.000367	CcSEcCtD
Ibandronate—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000321	0.000363	CcSEcCtD
Ibandronate—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000321	0.000363	CcSEcCtD
Ibandronate—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000318	0.00036	CcSEcCtD
Ibandronate—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000318	0.00036	CcSEcCtD
Ibandronate—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000317	0.000359	CcSEcCtD
Ibandronate—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000316	0.000358	CcSEcCtD
Ibandronate—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000309	0.000349	CcSEcCtD
Ibandronate—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000306	0.000347	CcSEcCtD
Ibandronate—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000306	0.000346	CcSEcCtD
Ibandronate—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000306	0.000346	CcSEcCtD
Ibandronate—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000304	0.000344	CcSEcCtD
Ibandronate—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.0003	0.000339	CcSEcCtD
Ibandronate—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000294	0.000333	CcSEcCtD
Ibandronate—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000292	0.00033	CcSEcCtD
Ibandronate—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000292	0.00033	CcSEcCtD
Ibandronate—Headache—Lamivudine—acquired immunodeficiency syndrome	0.00029	0.000328	CcSEcCtD
Ibandronate—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000288	0.000326	CcSEcCtD
Ibandronate—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000275	0.000311	CcSEcCtD
